Ticker Scorecard - TRML Basics Company: Tourmaline Bio, Inc. Common Stock IPO Date: May 3, 2021 Sector: Healthcare Industry: Biotech Market Cap: $313.1M Activated in VL: True Average Daily Range Avg Daily Range: $0.75 | 3.39% Avg Daily Range (30 D): $0.48 | 2.97% Avg Daily Range (90 D): $0.61 | 2.80% Institutional Daily Volume Avg Daily Volume: .22M Avg Daily Volume (30 D): .26M Avg Daily Volume (90 D): .19M Trade Size Avg Trade Size (Sh.): 63 Avg Trade Size (Sh.) (30 D): 58 Avg Trade Size (Sh.) (90 D): 50 Institutional Trades Total Inst.Trades: 181 Avg Inst. Trade: $1.57M Avg Inst. Trade (30 D): $1.18M Avg Inst. Trade (90 D): $1.08M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.12M Avg Closing Trade (30 D): $.56M Avg Closing Trade (90 D): $1.07M Avg Closing Volume: 109.56K     News Jul 4, 2024 @ 8:01 PM Thyroid Eye Disease Market to Accelerate Substanti... Source: Delveinsight Jun 27, 2024 @ 12:05 PM Tourmaline Bio Announces the Promotion of Ryan Rob... Source: Tourmaline Bio, Inc. May 23, 2024 @ 11:10 AM Tourmaline Bio to Present at the Jefferies Global ... Source: Tourmaline Bio, Inc. May 13, 2024 @ 11:00 AM Tourmaline Bio Reports First Quarter 2024 Financia... Source: Tourmaline Bio, Inc. Mar 21, 2024 @ 6:39 PM Why FactSet Research Shares Are Trading Lower By A... Source: Avi Kapoor Financials   TTM Q3 2024 Q2 2024 Basic EPS $18.51 $-.78 $-.68 Diluted EPS $18.51 $-.78 $-.68 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -48.85M $ -20.18M $ -17.49M Operating Income / Loss $ -78.82M $ -24.44M $ -21.97M Cost of Revenue $ $ $ Net Cash Flow $ -43.04M $ -35.14M $ -28.14M PE Ratio 0.66